{"transactions":[{"id":2206873,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-07-15T20:30:27.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":5000,"price":0.748,"value":3740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)"}],"balance_after":19915,"source":{"system":"sec-edgar","filing":"0001415889-22-007687","document":"form4-07152022_040709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922007687/form4-07152022_040709.xml","form_type":"4"}},{"id":2353756,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:16:28.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan.  Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-22-002297","document":"form4-03032022_010306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922002297/form4-03032022_010306.xml","form_type":"4"}},{"id":2454097,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-01-03T21:25:20.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":2655,"price":1.6575,"value":4400.6625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)"}],"balance_after":14915,"source":{"system":"sec-edgar","filing":"0001415889-22-000046","document":"form4-01032022_010104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922000046/form4-01032022_010104.xml","form_type":"4"}},{"id":2644256,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2021-07-02T20:11:08.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":2260,"price":1.9465,"value":4399.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":12260,"source":{"system":"sec-edgar","filing":"0001415889-21-003388","document":"form4-07022021_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003388/form4-07022021_040710.xml","form_type":"4"}},{"id":2925397,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T21:55:57.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-21-000016","document":"form4-01042021_010147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000016/form4-01042021_010147.xml","form_type":"4"}},{"id":2925396,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2021-01-04T21:55:57.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":5000,"price":0.4521,"value":2260.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on December 31, 2020 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-21-000016","document":"form4-01042021_010147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000016/form4-01042021_010147.xml","form_type":"4"}},{"id":3095089,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2020-07-01T21:33:05.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":5000,"price":0.448,"value":2240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\") on June 30, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-20-001766","document":"form4-07012020_020750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588920001766/form4-07012020_020750.xml","form_type":"4"}},{"id":3169002,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T21:10:51.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-20-001066","document":"form4-04272020_050436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588920001066/form4-04272020_050436.xml","form_type":"4"}},{"id":3389705,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-22T21:01:44.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-19-001213","document":"form4-10222019_051024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919001213/form4-10222019_051024.xml","form_type":"4"}},{"id":3510178,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T20:12:13.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option reported herein shall vest on Vesting Start Date May 23, 2019, and 1/36th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":150000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-19-000587","document":"form4-05282019_010500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919000587/form4-05282019_010500.xml","form_type":"4"}},{"id":3828561,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:21:28.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":125000,"derivative":{"exercise_price":1.5,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-18-001315","document":"form4-08312018_020812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001315/form4-08312018_020812.xml","form_type":"4"}},{"id":3828560,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:21:28.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-18-001315","document":"form4-08312018_020812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001315/form4-08312018_020812.xml","form_type":"4"}},{"id":3828559,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:21:28.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":80000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-18-001315","document":"form4-08312018_020812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001315/form4-08312018_020812.xml","form_type":"4"}},{"id":3828558,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:21:28.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-18-001315","document":"form4-08312018_020812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001315/form4-08312018_020812.xml","form_type":"4"}},{"id":3828557,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:21:28.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests monthly over a period of four years commencing 6/19/2016."}],"balance_after":180000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001415889-18-001315","document":"form4-08312018_020812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001315/form4-08312018_020812.xml","form_type":"4"}},{"id":3828556,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:21:28.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests monthly over a period of four years commencing 6/19/2016."}],"balance_after":0,"derivative":{"exercise_price":3.49,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001415889-18-001315","document":"form4-08312018_020812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001315/form4-08312018_020812.xml","form_type":"4"}},{"id":3851842,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-06T20:54:38.000Z","date":"2018-08-05","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.27,"expiration_date":"2028-08-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001227","document":"form4-08062018_010818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001227/form4-08062018_010818.xml","form_type":"4"}},{"id":4076110,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T21:55:55.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":200000,"derivative":{"exercise_price":1.16,"expiration_date":"2028-02-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-18-000188","document":"form4-02052018_010240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918000188/form4-02052018_010240.xml","form_type":"4"}},{"id":4204712,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-20T20:32:45.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date."}],"balance_after":100000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-17-001520","document":"form4-09202017_010935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588917001520/form4-09202017_010935.xml","form_type":"4"}},{"id":4341993,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-28T19:32:37.000Z","date":"2017-04-26","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-17-000681","document":"form4-04282017_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588917000681/form4-04282017_120426.xml","form_type":"4"}},{"id":4560585,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":125352,"kind":"person","name":"Smith Mark Alan","position":1,"cik":"0001677452","reported_name":"Smith Mark Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-11T01:30:33.000Z","date":"2016-11-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over a period of three years commencing November 9, 2016."}],"balance_after":80000,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-16-007388","document":"form4-11102016_081124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588916007388/form4-11102016_081124.xml","form_type":"4"}}]}